MYOCD and Hermansky-Pudlak syndrome: Our recent research has shown that myocardin levels decrease in PASMCs treated with HPS rat serum, and further studies identified myocardin as a direct target of miR-9 and demonstrated its involvement in mediating miR-9 effects on HPS rat serum-induced PASMC phenotypic modulation and proliferation.